Risk of Suicidal Ideation or Attempts in Adolescents With Obesity Treated With GLP1 Receptor Agonists DOI
Liya Kerem, Joshua Stokar

JAMA Pediatrics, Год журнала: 2024, Номер unknown

Опубликована: Окт. 14, 2024

Importance Glucagon-like peptide 1 receptor agonists (GLP1R) are increasingly being used for the treatment of obesity in adolescents. It is currently unknown whether GLP1R associated with suicidal ideation or attempts this population. Objective To investigate association between initiation and adolescents obesity. Design, Setting, Participants Retrospective propensity score–matched cohort study using electronic health records from TriNetX global federated network December 2019 June 2024. The analysis included data 120 care organizations, mainly USA. were aged 12 to 18 years a diagnosis evidence an antiobesity prescription lifestyle intervention without within following year. Cohorts balanced baseline demographic characteristics, psychiatric medications comorbidities, diagnoses socioeconomic status access score matching. Exposure Initial (study cohort) (control cohort). Main Outcomes Measures Incidence based on International Statistical Classification Diseases Related Health Problems, Tenth Revision codes recorded patient during months follow-up. Diagnoses upper respiratory tract infections (URTI) as negative control outcomes, gastrointestinal symptoms (GI) positive outcomes. Results A total 4052 concomitant identified 50 112 cohort. Propensity matching resulted 3456 participants each Prescription was 33% reduced risk over follow-up (1.45% vs 2.26%; hazard ratio [HR], 0.67; 95% CI, 0.47-0.95; P = .02) higher rate GI (6.9% 5.4%; HR, 1.41; 1.12-1.78; .003) but no difference rates URTI diagnoses. Conclusions Relevance In study, prescribed had lower incidence compared matched patients not who treated intervention. These results suggest favorable safety profile detected reduction HRs among suggests potential avenues future research.

Язык: Английский

Prevalence of suicidal thoughts and behaviors among young adults between 2000 and 2021: Results from six national representative surveys in France DOI Creative Commons
Mathilde M. Husky, Christophe Léon,

Enguerrand du Roscoät

и другие.

Psychiatry Research, Год журнала: 2024, Номер 333, С. 115763 - 115763

Опубликована: Фев. 2, 2024

The study examines the prevalence of 12-month suicidal thoughts and lifetime suicide behaviors among young adults between 2000 2021. Data were drawn from Health Barometer survey, a cross-sectional survey on French national representative sample. 2000, 2005, 2010, 2014, 2017, 2021 waves pooled to examine time trends in respondents aged 18 25 (n = 13,326), categorized based sex their occupational status: students, those employed, who are neither employment, education or training (NEETs). ideation (6.8 %) is no different that (7.0 %), despite U-shape curve between. In contrast, overall attempts was significantly higher as compared what observed average previous 21 years. multivariate models, females NEETs at greatest risk for behaviors. Additional attention prevention efforts needed reach training.

Язык: Английский

Процитировано

4

Insufficient Sleep is Associated With Increasing Trends in Adolescent Suicidal Behaviors DOI
Zijing Wang,

Yijia Tang,

Guangshuai Wang

и другие.

Journal of Adolescent Health, Год журнала: 2024, Номер 74(6), С. 1198 - 1207

Опубликована: Март 20, 2024

Язык: Английский

Процитировано

4

Adverse childhood experiences, gender, and suicidality among Florida high school students: Examining intervening mechanisms DOI
Melissa S. Jones, Salpi S. Kevorkian, Peter Lehmann

и другие.

Child Abuse & Neglect, Год журнала: 2024, Номер 153, С. 106834 - 106834

Опубликована: Май 4, 2024

Язык: Английский

Процитировано

4

The Prevalence of and Trend in Drug Use among Adolescents in Mississippi and the United States: Youth Risk Behavior Surveillance System (YRBSS) 2001–2021 DOI Open Access
Zhen Zhang, Amal K. Mitra,

Julie Schroeder

и другие.

International Journal of Environmental Research and Public Health, Год журнала: 2024, Номер 21(7), С. 919 - 919

Опубликована: Июль 14, 2024

Mississippi youth are demographically unique compared to those of the nation. The aim study was examine drug use among adolescents in that US, which included determining prevalence and trends as well drugs on school property estimating differences by gender race. National Youth Risk Behavior Surveillance System (YRBSS) data from 2001 2021 were obtained for analysis. Summary statistics, ratio, survey Chi-squared tests independence statistics generated comparison all students, race separately. Trend analysis conducted using logistic regression combined with joinpoint regression. six questions being studied following: have you ever used marijuana, an inhalant, heroin, methamphetamines, or injected drugs, offered, sold, given illegal during last 12 months. Survey packages R account complex sampling design YRBSS data. On national level, drug-related risk behaviors showed a significant decrease 2021. In Mississippi, however, only "ever marijuana" trend, while three remain unchanged, two increased. show exhibited significantly higher use, more likely be sold property. This research detailed findings use-related issues is alarming. poses important challenge public health sounds urgent call intervention adolescents. More concerted actions at community, government level needed reducing controlling traffic

Язык: Английский

Процитировано

4

Risk of Suicidal Ideation or Attempts in Adolescents With Obesity Treated With GLP1 Receptor Agonists DOI
Liya Kerem, Joshua Stokar

JAMA Pediatrics, Год журнала: 2024, Номер unknown

Опубликована: Окт. 14, 2024

Importance Glucagon-like peptide 1 receptor agonists (GLP1R) are increasingly being used for the treatment of obesity in adolescents. It is currently unknown whether GLP1R associated with suicidal ideation or attempts this population. Objective To investigate association between initiation and adolescents obesity. Design, Setting, Participants Retrospective propensity score–matched cohort study using electronic health records from TriNetX global federated network December 2019 June 2024. The analysis included data 120 care organizations, mainly USA. were aged 12 to 18 years a diagnosis evidence an antiobesity prescription lifestyle intervention without within following year. Cohorts balanced baseline demographic characteristics, psychiatric medications comorbidities, diagnoses socioeconomic status access score matching. Exposure Initial (study cohort) (control cohort). Main Outcomes Measures Incidence based on International Statistical Classification Diseases Related Health Problems, Tenth Revision codes recorded patient during months follow-up. Diagnoses upper respiratory tract infections (URTI) as negative control outcomes, gastrointestinal symptoms (GI) positive outcomes. Results A total 4052 concomitant identified 50 112 cohort. Propensity matching resulted 3456 participants each Prescription was 33% reduced risk over follow-up (1.45% vs 2.26%; hazard ratio [HR], 0.67; 95% CI, 0.47-0.95; P = .02) higher rate GI (6.9% 5.4%; HR, 1.41; 1.12-1.78; .003) but no difference rates URTI diagnoses. Conclusions Relevance In study, prescribed had lower incidence compared matched patients not who treated intervention. These results suggest favorable safety profile detected reduction HRs among suggests potential avenues future research.

Язык: Английский

Процитировано

4